Release date: 2015-09-17 The Imperial College of Science and Technology recently released a research report that a newly developed blood test technology can achieve a more efficient diagnosis of lung cancer in the experiment, and the whole detection process is simpler and cheaper than the traditional method, such as putting it into use. Helps cancer prevention and treatment. At present, the main method for diagnosing cancer is biopsy, that is, microscopic pathological examination of a small amount of diseased tissue or cell material of a patient, but the process is painful for the patient and needs to be performed by cutting, clamping or scraping. Not only takes a long time, but also costs a lot. Source: Health News Medical Device Consumables,Consumables Medical Products,Disposable Medical Paper Mouthpieces,Disposable Filter Spirometer Mouthpiece Hengshui Qifei Paper Products Co. LTD , https://www.hengshuiqifei.com
The blood test technology led by Imperial College researchers has identified patients with cancer by identifying cancer-related genetic variants in DNA.
Because of the preliminary experiment, the researchers narrowed the scope of the experiment to the diagnosis of lung cancer. They used a blood test and a traditional biopsy on 223 patients who may have lung cancer for comparison. Nearly 70% of patients diagnosed with blood tests have lung cancer, which is basically consistent with the results of biopsy. The blood test takes only a few days to get the results, and the process is faster.
The researchers said that although the experiment only targeted lung cancer, their analysis found that other types of cancer also showed similar genetic variability, which means that this blood test can be used in a wider range of cancer diagnosis in the future.